Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Ketamine Versus Dexmedetomidine for Delirium in Acute Heart Failure
NCT07781462Phase 4Not yet recruiting
- Sponsor
- Alexandria University
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 4, randomised trial of ketamine in delirium (2 arms), sponsored by Alexandria University. Primary endpoint: Resolution of delirium at 72 hours. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
ketamine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT07781462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07781462.